News on Nossan Srl from BioPortfolio.com http://www.BioPortfolio.com Consolidated Nossan Srl news from BioPortfolio.com Wed, 10 Feb 2010 13:39:11 GMT en Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042100&HITNO=0&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042100&THISHREF=http://c.moreover.com/click/here.pl%3fz2539314970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042100&HITNO=0&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042100&THISHREF=http://c.moreover.com/click/here.pl%3fz2539314970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042085&HITNO=1&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042085&THISHREF=http://c.moreover.com/click/here.pl%3fz2539307140%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042085&HITNO=1&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042085&THISHREF=http://c.moreover.com/click/here.pl%3fz2539307140%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North Americahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041920&HITNO=2&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041920&THISHREF=http://c.moreover.com/click/here.pl%3fz2539256036%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041920&HITNO=2&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041920&THISHREF=http://c.moreover.com/click/here.pl%3fz2539256036%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHouston Business Journal: Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041831&HITNO=3&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041831&THISHREF=http://c.moreover.com/click/here.pl%3fz2539236054%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041831&HITNO=3&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041831&THISHREF=http://c.moreover.com/click/here.pl%3fz2539236054%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Alexza Pharmaceuticals announces development and commercialization collaboration with Biovail Laboratories Internationalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041794&HITNO=4&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041794&THISHREF=http://c.moreover.com/click/here.pl%3fz2539226410%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041794&HITNO=4&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041794&THISHREF=http://c.moreover.com/click/here.pl%3fz2539226410%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North Americahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041774&HITNO=5&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041774&THISHREF=http://c.moreover.com/click/here.pl%3fz2539223715%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041774&HITNO=5&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041774&THISHREF=http://c.moreover.com/click/here.pl%3fz2539223715%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCharlotte Business Journal: Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North Americahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041770&HITNO=6&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041770&THISHREF=http://c.moreover.com/click/here.pl%3fz2539223408%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041770&HITNO=6&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041770&THISHREF=http://c.moreover.com/click/here.pl%3fz2539223408%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBaltimore Business Journal: Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041757&HITNO=7&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041757&THISHREF=http://c.moreover.com/click/here.pl%3fz2539222060%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041757&HITNO=7&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041757&THISHREF=http://c.moreover.com/click/here.pl%3fz2539222060%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North Americahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041754&HITNO=8&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041754&THISHREF=http://c.moreover.com/click/here.pl%3fz2539221250%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041754&HITNO=8&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041754&THISHREF=http://c.moreover.com/click/here.pl%3fz2539221250%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKansas City Business Journal: Biovail and Alexza Pharmaceuticals sign collaboration and license agreement for anti-agitation drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041748&HITNO=9&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041748&THISHREF=http://c.moreover.com/click/here.pl%3fz2539219737%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041748&HITNO=9&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041748&THISHREF=http://c.moreover.com/click/here.pl%3fz2539219737%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041691&HITNO=10&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041691&THISHREF=http://c.moreover.com/click/here.pl%3fz2539206681%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041691&HITNO=10&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041691&THISHREF=http://c.moreover.com/click/here.pl%3fz2539206681%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North Americahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041685&HITNO=11&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041685&THISHREF=http://c.moreover.com/click/here.pl%3fz2539204871%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041685&HITNO=11&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041685&THISHREF=http://c.moreover.com/click/here.pl%3fz2539204871%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041680&HITNO=12&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041680&THISHREF=http://c.moreover.com/click/here.pl%3fz2539203153%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041680&HITNO=12&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041680&THISHREF=http://c.moreover.com/click/here.pl%3fz2539203153%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041671&HITNO=13&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041671&THISHREF=http://c.moreover.com/click/here.pl%3fz2539201558%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041671&HITNO=13&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041671&THISHREF=http://c.moreover.com/click/here.pl%3fz2539201558%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comForbes.com: Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North Americahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041663&HITNO=14&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041663&THISHREF=http://c.moreover.com/click/here.pl%3fz2539198735%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041663&HITNO=14&MSIZE=79&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Nossan%20Srl&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041663&THISHREF=http://c.moreover.com/click/here.pl%3fz2539198735%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTriad Business Journal: